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Medical devices are essential for the successful delivery of almost every form of health care. 
The medical device industry is currently one of the fastest-growing and dynamic sectors of 
the global economy. However, the global market is heavily dominated by high-income 
countries (HICs) with low to middle-income countries (LMICs) constituting only 13% of the 
global market. As a result, up to 80% of medical devices in LMICs are donated or imported. 
A medical device needs to be appropriate for the context in which it is intended. Imported 
medical devices, which are manufactured for use in high-income countries, however, are 
often inappropriate and ineffective when used in low-resource settings. This results in 
approximately 40% of donated/imported medical devices being out of service, 70–90% never 
functioning as intended, and up to 98% broken within five years. The lack of appropriate 
medical devices in LMICs suggests the need for a shift towards a more human-centred, 
design-orientated medical device industry, which promotes local manufacture. Like many 
LMICs, South Africa’s local medical device industry is underdeveloped. Approximately 90-
95% of medical devices in South African hospitals are imported/donated. However, in a 2014 
World Health Organisation feasibility study, South Africa showed great capacity to support 
the local production of medical devices. Furthermore, recent success stories such as Jed 
Aylmer’s Symba paediatric bed indicate that local designers and manufacturers can 
successfully compete with international suppliers of sophisticated equipment - highlighting 
an opportunity for increasing medical device design in South Africa. This paper presents the 
design process followed in the development of Symba in the form of a retrospective case 
study. The purpose of the paper is to share appropriate local design strategies, which better 
enable local industrial designers to pursue more appropriate medical device design outcomes 
in the South African context.  
 





Hospital environments, designed appropriately, can promote healing and enhance operational 
efficiency (McAndrews, 2005:7). Medical devices (MDs) used by staff and patients in 
hospitals are a large contributing factor to what constitutes a “hospital environment”. 
However, there is scant literature on the importance or effect of medical device development 
(MDD) and its effect on the hospital environment and experience. This highlights an 
opportunity for involving designers in the MDD industry, moving past the purely functional 
approach of biomedical engineers, towards a more human-centred design approach. 
 
The MD industry is one of the fastest-growing and dynamic sectors of the global economy 
(Frost & Sullivan, 2017; World Health Organisation, 2010:14). Despite rapid progress within 
the development of medical technologies, the fact that MD innovation is mainly targeted at 
high-resource contexts means that the majority of the world’s population lack access to MDs 
that are appropriate for their specific epidemiological needs (Cheng, 2003; World Health 
Organisation, 2010; World Health Organisation, 2016; Dyro, 2004). 
 
The lack of appropriate MDs, particularly in low to middle-income countries (LMICs) 
suggests the need for a shift towards a more human-centred, design-orientated MD industry, 
which promotes local manufacture. This paper reports on a retrospective case study of the 
design of the Symba Paediatric Hospital bed by Industrial Designer Jed Aylmer, of Praestet 
Healthcare Design, for the Nelson Mandela Children’s Hospital (NMCH) as a means to 





Design for Healthcare 
For most people, illness is a source of stress that is further aggravated when placed into a 
healthcare setting, an environment where many people experience strong emotions of fear 
and anxiety (Kopec, 2012:261; Dellinger, 2009:49). Stress not only affects patients in 
hospitals but is also a very intense emotional experience for healthcare providers (Dellinger, 
2009:48). ‘Product experience’ refers to the subjective experiences involved in human-
product interaction (Desmet & Hekkert, 2007; Desmet, 2004). When people interact with 
products emotions are elicited by one’s judgement of the significance of a situation’s benefit 
or harm for one’s well-being (Scherer, 2001; Desmet & Hekkert, 2007). A growing body of 
research recognises that well-designed physical settings play an important role in making 
hospitals safer, more efficient, and less stressful, promoting healing for patients and 
improving the work environment for staff (Zimring, Augenbroe, Malone, & Sadler, 2008; 
McCullough, 2009).  
 
MDs are essential for the successful delivery of almost every form of health care and 
improvement of the health of individuals and populations (World Health Organisation, 2010). 
Staff and patients are exposed to and interact with MDs for most of their time in hospitals. 
When designed appropriately, hospital environments can reduce stress and promote healing 
ultimately improving recovery time (McAndrews, 2005:7; Kopec, 2012). Furthermore, 
design can enhance usability and operational efficiency while reducing the chance of human 
error, further improving the work experience for staff. Providing environments that help 
mitigate stress and enhance operational efficiency should, therefore, be a primary concern 
when developing and designing healthcare facilities (Kopec, 2012:261). This suggests the 
importance of the appropriate design of MDs, suited to the emotional and functional needs of 
users.  
 
Technological Diffusion, Context and the Mismatch 
Not only do MDs need to be appropriate for the psychological and clinical needs of users, but 
they need to be appropriate for the context or setting in which they are used. One of the main 
barriers to the optimal use of MDs in LMICs is the “mismatch” between the design of the 
device and the context in which it is ultimately used (World Health Organisation, 2010). For 
decades, developed countries have exported MDs from ‘developed’ to ‘developing’ settings 
in the form of low-cost sales or donations (Dyro, 2004). As a result, up to 80% of MDs in 
LMICs are donated or imported (World Health Organisation, 2011:8). In many cases, 
donations bypass local procurement systems of the recipient country, and as a result, actual 
local requirements, capabilities, and the available level of technical expertise to provide 
maintenance, are not considered appropriately (World Health Organisation, 2011:8). It is also 
common for multinationals to “strip down” devices, originally intended for High Income 
Country (HIC) markets, for LMICs rather than developing products specifically designed for 
their contexts (World Health Organisation, 2012:16). Donated MDs are rarely accompanied 
by ongoing maintenance, user training and technical support (Prestero, 2010:86; Dyro, 
2004:155). As a result, although MDs may be available in LMICs, they are often ill-suited 
for local conditions and therefore cannot be used effectively (World Health Organisation, 
2010). As a result, approximately 40% of MDs in LMICs are out of service, 70–90% of all 
donations never function as (Malkin & von Oldenburg Beer, 2013:1847; Chan, 2010); and up 
to 98% of donated medical equipment is broken within five years (Prestero, 2010:86). 
 
Appropriate Technology through Local Production  
The WHO identifies local production as a way to increase access to appropriate MDs in 
LMICs (World Health Organisation, 2016:1). In a 2014 study, SA showed great capacity to 
support local production of MDs (World Health Organisation, 2016). Furthermore, recent 
success stories (Praestet, 2020; CapeRay, 2018; Lodox, 2015) indicate that local designers 
and manufacturers can successfully compete with international suppliers of sophisticated 
medical equipment. However, except for a handful of examples, SA’s MD industry is still 
relatively underdeveloped. Most local industry is constituted of multinational subsidiaries, 
importers and distributors with very little local design and manufacture (Mitchell, 2017; 
KPMG, 2014:11-12).  Like many LMICs, approximately 90-95% of MDs in South African 
hospitals are imported or donated (Mitchell, 2017). Local MD production consists mostly of 
small to medium-sized businesses combining distribution activity with manufacturing, which 
is limited mostly to consumables, basic hospital furniture and low technology items 
(SAMED). The lack of MDD in SA could be attributed to the complexities of designing for 
healthcare, such as navigating expensive regulatory controls and certifications (Mitchell, 
2017); the myriad of end-users and stakeholders (Kopec, 2012:268; Ogrodnik, 2012); the 
social complexities of designing in “developing/third-world” countries (Prestero, 2012); the 
lack of formal MDD training in South African institutions; and finally, until June 2017, the 
absence of a MD regulatory framework/body in SA.  
 
 
RESEARCH DESIGN  
 
The design and planning phase of this study involved five steps: conducting a literature 
review, identifying a research problem/project aim, constructing a theoretical framework, 
designing research questions and interview schedules, and purposively selecting the 
sample/case (Merriam, 1998) 
 
Literature Review  
This study began with an in-depth review of the relevant literature for the construction of the 
research aim and questions and theoretical framework that would guide the inquiry (Merriam, 
1998) Reflecting on a body of literature, three key themes/factors/omissions were identified. 
Firstly, the most notable influence on MDD is the regulatory requirements1 of MD 
development and manufacture; secondly, the complexity of the number and variety of 
stakeholders and/or users involved throughout the process; and thirdly, very few of the 
authors referred to contextual considerations outside of regulatory/standards concerns. 
 
Regulatory Controls & Context 
Although the scope of this paper doesn’t delve into the specific complexities of MDD 
controls and regulations, it is important to note that all authors refer to European (CE) and 
                                                 
1 The scope of this paper does not delve into the specific complexities regarding MDD controls and regulations. For more detail on this, 
refer to (Bullock, 2019), Chapter 2 and 7. 
United States (FDA) regulatory requirements and processes. It is also important to note that 
until 2017, SA lacked its own regulatory body, and has very limited/outdated design 
standards related to MDs. Therefore any MDs designed or procured would have to 
reference/meet the requirements of international (European/USA) standards; hence the 
contextual mismatch. Furthermore, the significant cost involved in getting approved by these 
international bodies is a potential limiting factor to local MDD.  
 
Stakeholders  
For a MD to be considered successful, it must be clinically effective, safe and meet the needs 
of the several people using and being treated by the device (Martin, Clark, Morgan, Crowe, & 
Murphy, 2012:184; Santos, Gazelle, Rocha, & Tavares, 2012). This highlights the importance 
of meeting user needs, however, defining who a MD user is, can be far more complicated 
than it seems (Teixeira, 2014:13). MD users are not a homogenous group, but rather, consist 
of various people each with different roles and interests (Shah, Robinson, & Alshawi, 
2009:3). The term user can refer to patients, nurses, doctors, clinical specialists, carers, 
cleaners, maintenance staff, friends and family members (Shah, Robinson, & AlShawi, 
2009:3; Teixeira, 2014:13). Furthermore, other stakeholders, such as regulatory bodies, 
manufacturers, investors, procurement officers and hospital management also have needs, 
requirements and expectations which the designer and device must accommodate (Shah et al., 
2009:3). Various authors, therefore, stress the importance of forming multi-disciplinary 
project teams to identify and understand the needs of these users and to understand the 
system of which the device is a part (Martin et al., 2012:184; Money et al., 2011: 1).  
 
Problem identification and Research Aim  
The synthesis and review of the existing literature identified that although various MDD 
process models and case studies documenting appropriate MDD have been defined, none of 
them describes the South African MDD regulatory landscape; and most describe the MDD 
process from an engineering or business perspective rather than a design point of view. As a 
result, ‘design’ is portrayed as a step in the overall development process. The absence of 
design-related insights in existing MDD literature, and the lack of documentation of local 
MDD outcomes/processes, informed our decision to conduct a case study documenting MDD 
from a designer's perspective. The aim of this study was therefore to document the design 
process and outcome of an appropriate South African MD as an example of how to design 
appropriate MDs for LMIC contexts.  
 
Theoretical Framework  
Framed within the pragmatic paradigm, the purpose of this study was to generate 
prescriptive/guiding design knowledge and serve as an example of best practice for the 
design and manufacture of appropriate MDs in LMICs (Goldkuhl, 2012:8; Zimmerman, 
Stolterman, & Forlizzi, 2010:313). In this study, constructive knowledge was formulated and 
supported by the interpretivist elements of interpretation and understanding of the 
perceptions and lived experiences of participants, through a case study (Thanh & Thanh, 
2015:25; Goldkuhl, 2012:15; Munro, 2014). 
 
Research Objectives 
Using the case study method, this study explored and analysed a local, design-led product 
design process and outcome of a MD to identify the:  
1. challenges, shortfalls and problems faced in the process and how they were overcome 
2. stakeholders/key role-players in the design process, their involvement and impact on 
the design process 
3. design considerations and their effect on the outcome. 
 
These objectives, informed by the literature review, guided the provisional set of interview 
questions (Gray, 2004). 
 
Case Selection 
To ensure the gathering of valuable information, the chosen case had to meet four 
predetermined criteria. First, the case had to represent an industrial design-led project (not 
engineering or biomedical perspective) to provide appropriate design-related information. 
Second, to ensure the entirety of the design process could be documented, the case had to 
have been an already completed project. This was, therefore, a retrospective case study 
(Starman, 2013). Third, the case had to have been documented to some extent outside of this 
case study to allow for fact-checking and data triangulation (Flick, 2004). Lastly, the case had 
to represent the correct context, therefore it had to be a South African design/product. Based 
on these selection criteria, Symba, the paediatric hospital bed designed and manufactured by 
Praestet was purposively selected as the case. 
 
Methods 
To enhance the rigour, credibility and validity of this research, this study adopted the strategy 
of triangulation of data, whereby data was gathered using multiple methods and sources 
(Gray, 2004; Baxter & Jack, 2008). Before conducting interviews, preliminary 
desktop/background research was conducted to establish a basic understanding and overview 
of the case and the South African MDD context (Kothari, 2004:111). In Praestet’s case, the 
design and development of Symba were relatively un-documented. Therefore the primary 
data gathering tool was semi-structured interviews. This case began with an introductory 
interview and an overview analysis of the process. Thereafter, the in-depth retrospective 
visualization of Praestet's process took place over a series of nine ‘brainstorm sessions’ over 
five months. All interviews were recorded using written notes, mind mapping (Fig. 1), audio 


















Once all the data had been externalized, we began a process of classification, searching for 
and reviewing potential themes by rearranging the data, finding areas of similarity and 
clustering words related to similar concepts together or according to objectives 1-3 (Braun & 
Clarke, 2012; Kolko, 2010). This analysis took place in a four-hour-long design session 
Figure 1: Aylmer’s Spatialization process, 2018 (author) 
whereby the pages produced over the five months were condensed and summarised into a 
single page/model through a spatialization process (Kolko, 2010). To further enhance the 
validity of this research, the case was interpreted from three viewpoints (summarised by the 
author in three visual formats: a timeline, process model and tabulated overview) providing a 
complete, thick case description (Gray, 2004; Baxter & Jack, 2008). 
 
Once data collection and analysis were completed the case was documented in an in-depth 
case report (Baxter & Jack, 2008). To ensure or enhance the credibility of this research, the 
case report and process models were reviewed by the participant to verify accuracy, 
completeness, terminology correctness and redundancy (Gray, 2004; Yin, 1981; Medina, 
Okudan Kremer, & Wysk, 2013).  Finally, to fully understand and accurately interpret 
findings, case study data were compared with published literature of existing MDD process 




CASE STUDY  
 
In 2013, Jed Aylmer was a BTech Industrial Design student at the University of 
Johannesburg (UJ). To complete the programme, Aylmer was required to undertake a 
practical final semester-long design project of his choosing; this was documented in the 
format of a mini-dissertation. Aylmer saw an opportunity to use his university project to 
design a MD for the visionary NMCH paediatric healthcare facility (Aylmer, 2017a). 
 
A hospital bed forms the environment in which a child patient spends most of their time when 
in hospital, it is also the object in which parents see their child during hospitalization 
(Aylmer, 2013). A variety of paediatric hospital beds are available on the market however the 
bed most commonly found in South African paediatric wards is the steel cot (Fig. 2), as it can 
be used for both young toddlers and children up to the age of five years old (Aylmer, 2013). 
The design and overall cage aesthetic of these cots have remained the same as beds used in 
the 1920s. According to Aylmer, the cage-like appearance of most paediatric beds “subject[s] 
children to a psychologically disturbing micro-environment” (Aylmer, 2013). Furthermore, 
observations indicated that the outdated tubular steel construction acts as a hindrance to 
medical professionals’ access to the child during respiratory procedures (Aylmer, 2013) and 
creates various safety hazards for nurses, with reports of the heavy steel cot side falling into 















Figure 2: Hospital cot at Rahima Moosa Mother and Child Hospital (Aylmer, 2013) 
Aylmer set out to redesign an appropriate paediatric hospital cot that offered an alternative to 
the cold cage-like beds that he had observed (University of Johannesburg, 2017; Aylmer, 
2013). He aimed to improve the product experience of the primary user, the child, and 
product usability, safety and accessibility by considering the needs and requirements of 
medical professionals by addressing/improving aesthetics, material choice, durability, 
accessibility, manufacture quality and audible properties (University of Johannesburg, 2017; 
Aylmer, 2013). Completing the university project in November 2013, Aylmer has since gone 
on to develop and manufacture his paediatric hospital bed and founded a MD design and 
development company, Praestet (Pty) Ltd.  
 
Design Process Model/Description 
Various authors have attempted to visualize process models that describe the MDD 
landscape, however, most diagrams speak to a linear process, which fails to accurately 
describe the various loops, turns and stops that occur in reality (Ogrodnik, 2012:32). Aylmer 
described a “plasmodial soup model” (Fig. 3), an attempt to visually depict how the design 
process, design thinking and design outcome are constantly changing as the designer operates 
within and is affected by various external influencing factors such as users, stakeholders, 
regulations and standards, considerations and context. According to Aylmer, this balancing 
act compromises of five factors: the singular perception, the nexus cloud, the premise, 



























The singular perception refers to the designer’s own goals of what the product should be. 
Aylmer’s “singular perception” was to improve overall product experience by addressing the 
emotional and functional requirements of users (Aylmer, 2018b). The premise represents the 
designer’s interpretation of the end-users’ needs. The nexus cloud refers to all tangible 
Figure 3: Aylmer's plasmodial soup model summary, 2018 (author) 
(physical/written) and intangible (thought/feeling) factors (relevant and irrelevant) 
influencing the design process. “Tangible factors” included: standards, manufacturing 
constraints, market variables, context/locale and design considerations. “Intangible factors” 
included: external influences, experiences and feelings (Aylmer, 2018i). As the process 
progressed, the nexus cloud grew/changed as more information became available (Aylmer, 
2018i). Transmutation refers to the act of translating the relevant information (identified and 
drawn from the nexus cloud) into a device design to best satisfy the user (Aylmer, 2018i; 
Aylmer, 2018j). Aylmer explained that the tensions between the internal influences of the 
user and designer and external influences, constantly morphed and shaped the process, 
resulting in various iterations. Finally, the Fragile Culmination is the design outcome that 
represents the best compromise between all of the above. The “fragile culmination” was the 
point of resolution that best suited the product requirements, specific to its context (the 
nexus) (Aylmer, 2018i; Aylmer, 2018j). 
 
Analysis of Aylmer's description of his process identified three key categories/influences in 
the nexus cloud: user needs, stakeholder needs (manufacture and regulators), and financing 
and project management. 
 
User Needs 
To understand the needs of users/stakeholders of a MD, one must also understand the 
context/s in which it operates. Aylmer consulted with and gathered insights from over 150 
nurses, doctors and health professionals throughout the process through interviews, 
questionnaires, panel discussions, prototype testing and clinical evaluations (Aylmer, 2017a). 
 
Symba was designed for children between the ages of 6-months to 6-years-old. From a 
human-centred design perspective, Aylmer acknowledged that the challenge of designing for 
paediatrics is that the primary “exposed” end-user cannot directly inform the process through 
communicating their needs, wants and feelings (Aylmer, 2017a). Therefore, Aylmer had to 
uncover insights using methods such as observation, looking at the way that children interact 
with objects, case studies and psychological research (Aylmer, 2017a). The second group of 
users identified by Aylmer included patients’ parents or guardians, medical doctors and 
nurses (Aylmer, 2018k). Although classified as “secondary users”, Aylmer acknowledged 
that this group of users were in fact “also primary users” because they utilise the product on 
the outside where a child utilises the product from the inside (Aylmer, 2017a). A significant 
amount of insights and data were collected from secondary users throughout the Symba 
design and development process. According to Aylmer, secondary users focused on medical 
functionality and operational and usability concerns (Aylmer, 2017a). Aylmer also consulted 
with various discipline experts including biokineticists, physiotherapists, psychologists and 
hospital procurement officers. Aylmer acknowledged that all users, informants and 
stakeholders have different perspectives and that the design process is very much about 
balancing those different perspectives to come to a compromise (Aylmer, 2017a). 
 
Stakeholder Needs  
Aylmer identified regulations, standards and manufacturing considerations as a key 
challenge/influencing factor in the MDDes process (Aylmer, 2017a). “The medical realm is 
particularly complicated because manufacture, engineering and design have to follow and 
work around the regulatory constraints and rules that are given and dictate how a product 
should be designed” (Aylmer, 2017a). Aylmer (Praestet) was both the designer and 
manufacturer (in the regulatory sense), working in close relation with local suppliers, 
manufacturers and a team of biomedical engineers (BMEC). Aylmer worked with 
approximately 16 different manufacturing suppliers who provided practical knowledge 
regarding the constraints and costs of manufacture (Aylmer, 2018k). The team of biomedical 
engineers at BMEC was responsible for assessing the stresses, strains and sheer points on 
parts and provided guidance/assistance regarding safety and the certification procedures and 
requirements (Aylmer, 2018k). Aylmer’s role as the designer was to balance the information 
coming from the biomedical engineers and the constraints of manufacture while maintaining 
his design intent. As part of the CE Marking application process, Aylmer elected an 
Authorised Representative (from Sweden) with whom he consulted during the compilation of 
the technical file (Aylmer, 2018k).  
 
Financing and Project Management 
Aylmer defined the overarching challenge as getting the device to fruition by combining 
money, planning, timing and luck. Securing funding, knowing where to turn to next, knowing 
where in the process you are, and how to get to “the end” were all “massive challenge[s]”; all 
of which he claims to “still face daily” (Aylmer, 2017a). Securing funding throughout the 
project was particularly challenging. Aylmer approached various public and private investors 
and funding organisations throughout the project. The two most significant donors/funding 
agencies involved in the product development phase of the project were the UJ Technology 
Transfer Office (TTO) and the Technology Innovation Agency (TIA) seed fund, which 
financed the build of the full-scale prototype and certification.  Working as a sole-designer, 
manufacturer and business owner in SA, Aylmer stressed the importance of strong 
partnerships (Aylmer, 2017a). Aylmer identified the NMCH trust as a key partner throughout 
the process because, although not directly involved in the project, their interest and support 
stimulated the undertaking of the process in the first place (Aylmer, 2017a; Aylmer, 2018k). 
The UJ TTO was also identified as a key partner during the project, assisting with initial 
funding, early-stage commercialisation advice, structuring the initial stages of the business 
plan, intellectual property protection, and assisting with initial refinement on the product, 
through Resolution Circle’s team of engineers (Aylmer, 2017a; Aylmer, 2018k). 
 
 
CONSIDERATIONS, REQUIREMENTS AND DESIGN OUTCOME 
 
Aylmer’s initial four guiding design principles (based on his singular perception) were: cage, 
rust, get-in and squeak. These principles spoke to product experience, material 
choice/durability, safety/accessibility, and manufacture quality (2017a). While navigating the 
various views, insights, requirements and considerations of the role players and factors in the 
nexus cloud, the core design considerations can be divided into functional considerations 
(safety, hygiene, access, mobility, medical functionality and usability) and product 
experience/aesthetics (Aylmer, 2017a).  
 
Appropriate Product Experience and Aesthetics  
Appropriate aesthetics can reduce stress for patients and improve clinical adoption leading to 
more staff using it, and using it more often (Core77 , 2016). According to Aylmer, MDDes is 
about perception (Aylmer, 2017a). “Hospitalisation is a horrible experience” and his primary 
concern was, therefore, that of product experience (Aylmer, 2017a). Aylmer’s goals were to 
reduce the psychological impact of the cage-like beds on child patients through 
revaluating/re-approaching aesthetics and the way that it appealed to the senses (Aylmer, 
2017a), and to meet the needs of nurses who “also want to feel that they’ve got products in 
their ward that inspire confidence in the product and the equipment that they have” (Aylmer, 
2017a). Abandoning the heavy cold steel cage-like bars of existing cots, Symba’s injection 
moulded clear cot side panels provide visibility (visual access) of the patient while allowing 
patients to feel less constrained by the cot. This also creates an environment in which the 
child can engage with parents, medical professionals and other patients. The soft forms and 
bright colours of Symba’s body “bring life to hospital rooms” and create a softer, more 
comforting environment for children (Praestet, 2020). The high-tech, high quality aesthetic of 
Symba, far removes it from the old, “basic” aesthetic of the metal cages, which improves 
faith and pride in the product and its clinical efficiency. Aylmer also paid particular attention 
to the sound of the device (such as wheels, buttons, brakes) and the effect of these sounds on 
the patient environment (Aylmer, 2018b). The change in material, from cold hard metal to a 
warm soft plastic drastically changes the aesthetic, tactile and audible/sound quality of the 






















Appropriate functionality, safety and maintenance 
The change in material, manufacture and form-giving/aesthetics not only improved product 
experience but also addressed the functional requirements of safety, hygiene, access, 
mobility, medical functionality, usability. The seamless design of the rotational moulded 
main components are easier to clean and reduce the chances of bacteria hiding in crevices, 
improving hygiene and infection control (Praestet, 2020). The individually operated cot sides 
are controlled using a dual-locking spring system, allowing the user to position each cot side 
in four safety configurations, locking properly and securely into place quickly in an 
emergency (Praestet, 2020). The spring system reduces strain on nurses when operating the 
sides and prevents injury/risk of collapsing/dropping sides. Unlike existing cots, each cot side 
can be lowered, providing access to the patient, from all sides, which improved 
usability/operation during respiratory procedures (Praestet, 2020). Symba has four, lockable, 




Although Symba was designed in and for the South African context, Aylmer explained that 
the South African Bureau of Standards (SABS) did not have a recent standard for paediatric 
Figure 4: Symba Paediatric Hospital Bed (Praestet, 2020) 
hospital beds. According to Aylmer (2018a), the German Institute for Standardization (DIN), 
had the most comprehensive standard for paediatric hospital beds (DIN 32623:2009-11) and 
he, therefore, referred to that standard when designing Symba. Furthermore, he explained 
that, at the time, SA had no local regulatory authority or framework in place. Aylmer, 
therefore, chose to pursue CE Marking certification as it would allow him to trade in Europe 
and made good business sense as the CE Marking is an international “mark of quality” that 
many procurement agencies look for when choosing MDs (Aylmer, 2018a). 
 
   
FINDINGS AND DISCUSSION 
 
Design is the process 
When comparing Aylmer's design process to that seen in existing literature, two similarities 
were identified. Firstly, Aylmer’s MDDes description of the nexus cloud links strongly to an 
existing MDD process description of a data cloud (Ogrodnik, 2012:88). Both of these 
“clouds” describe the various regulatory, market, user, IP, manufacture (and more) 
considerations that “float around” the project and influence the design process. The 
difference, however, is that Ogrodnik speaks only to the data cloud when defining product 
specifications at the beginning of the process. Aylmer’s description differs in the sense that 
he described the nexus cloud as a constant undertaking at every step and within every phase 
of the project. Secondly, one can draw similarities between Aylmer's "Plasmodial Soup 
Model" and IDEOs model of innovation (Fig. 5), whereby ‘design’ is described as the 
balancing act of feasibility, viability and desirability, and achieving a balance of all three of 
these constraints will arrive at successful, innovative outcomes (Brown, 2009:18). Similarly, 
Aylmer’s model depicts the balance and alignment of the designer’s goal, the user needs, 
design activities and feasibility and viability concerns as defined in the nexus cloud. The 
overlap, the “fragile culmination” refers to the design outcome that serves as the best 
compromise of all factors. It is interesting to note that Aylmer’s process description links to 
IDEOs description of design thinking (IDEO, 2015). This highlights that design and design 
thinking are fundamentals of the MDD (hence the new term MDDes used in this paper) 



















Figure 5: Plasmodial soup model and IDEO constraints model comparison, 2018 (author) 
Human-Centred vs Regulation-Centred 
User involvement in the MDDes process increases the likelihood of producing MDs that are 
safe, usable, compliant, clinically effective and appropriate to cultural context (Money et al., 
2011:3; Shah et al., 2009:4; Martin et al., 2012:189). The fact that the Symba project was led 
by an industrial designer is evident in the fact that early phases focused mostly on 
desirability/human-centred concerns first (emotional and functional needs of users), then only 
followed by market, feasibility, and viability and regulatory concerns. The main difference 
between Aylmer's case and process outlined in the literature was the significant focus on user 
involvement throughout the whole process with a strong focus on human factors and product 
experience, not only standards and regulatory controls and requirements.  
 
Locally suited to an international Standard 
Aylmer’s need to pursue CE Marking certification highlighted a significant insight that up 
until very recently (2017) SA had no framework in place to regulate and monitor MDs. The 
absence of an established regulatory framework in SA may explain the limited local MDD 
activity. As a result, Aylmer had to refer to European standards and regulations. In a way, this 
served as an advantage in Aylmer's case. Unlike products that are designed to suit 
international standards in international contexts, designing and manufacturing a device for 
and within the South African context allowed Aylmer to consult frequently with local 
experts, with experience valuable insight into the appropriate design of this bed. The design 
of Symba was informed by the South African context and local experts and experiences while 
meeting the quality requirements of international (European) standards and regulations. In 
doing so, the product is suited to local needs, while maintaining an international standard. 
This debunks the notion that products in LMICs should be stripped-down versions of 1st 
world products. Furthermore, suited to international contexts, allows for exporting and 
industry participation. Symba has since been exported and shown at international expos, 
showing that although this device is suited to the local context, it holds its own in 
international HICs as well.  
 
Locally Trained & Maintained 
Symba is manufactured locally. This allows for appropriate training, maintenance, 
monitoring and design improvements (none of which are available when a device is 
donated/imported). The ability to maintain the product, without waiting for months at a time 






The introduction of a new regulatory framework in SA serves as an opportunity for increased 
local development of MDs. This case study serves as an example of how MDs should be 
designed to be appropriate for user's needs, but also benefit local design and manufacture 
towards good quality, suitable outcomes for an LMIC context, and the world. This case study 
showed that, for a MD to be appropriate in LMICs, it must be design-led, human-centred, 
contextually-embedded, locally manufactured and supported, whilst meeting the requirements 
of quality/international standard, which in turn offers the potential for international retail 
opportunities. 
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